1-3 of 3
M Moyer
Close
Sort by
Journal Articles

Determination of Relapse Risk By Complement Gene Variants after Eculizumab Discontinuation in Complement-Mediated Thrombotic Microangiopathy: A Retrospective Review

Aldo A. Acosta-Medina, MD, Ann M. Moyer, MDPhD, Ronald S. Go, MD, Maria Alice V. Willrich, PhD, Hassan B. Alkhateeb, MD, Christianne Bourlon De Los Rios, MDMSc, Dong Chen, MD, PhD, Fernando C. Fervenza, MDPhD, Nahla M. Heikal, MD, Nelson Leung, MD, Ariela L. Marshall, MD, Cheryl L. Tran, MD, Jeffrey L. Winters, MD, Meera Sridharan, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 25–26.
https://doi.org/10.1182/blood-2020-136617
Published: 2020
Journal Articles

Single Nucleotide Polymorphisms (SNPs) in Genes for Glutathione-Related Metabolism, Cyclin D1, and DNA Repair As Predictive Biomarkers in Mantle Cell Lymphoma Patients Treated with R-HyperCVAD with Ten Year Clinical Follow-up,

Michael A. Thompson, MD, PhD, Caimiao Wei, PhD, Ann M Moyer, PhD, Julie M Cunningham, PhD, Luhua Wang, MD, Luis Fayad, MD, Lei Feng, Ph.D, Maria Alma Rodriguez, MD, Fernando Cabanillas, MD, Hagop M. Kantarjian, Larry W Kwak, MD, PhD, Jorge E Romaguera, MD
Journal: Blood
Blood (2011) 118 (21): 3650.
https://doi.org/10.1182/blood.V118.21.3650.3650
Published: 2011
Journal Articles

5-Azacytidine increases HbF production and reduces anemia in sickle cell disease: dose-response analysis of subcutaneous and oral dosage regimens

GJ Dover, S Charache, SH Boyer, G Vogelsang, M Moyer
Journal: Blood
Blood (1985) 66 (3): 527–532.
https://doi.org/10.1182/blood.V66.3.527.527
Published: 1985